LPCN · Lipocine Inc. · Share Buybacks
Market Cap
$18.71M
Shares
8.24M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-04-26 | — | $50,000,000 | — | — | 10-K , filed 2026-03-10 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Quarter Ended | Cash Spent | Source |
|---|---|---|
| 2024-03-31 | $8,100 | 10-Q, filed 2025-05-08 |
| 2014-09-30 | $0 Δ | 10-Q, filed 2014-11-10 |
| 2013-09-30 | $0 Δ | 10-Q, filed 2014-11-10 |
Key facts
CIK
1535955
CUSIP
53630X203
13F (30d)
16 filings
16 filers
Visit website
Investor relations